9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore.
about
Facile synthesis of octahydrobenzo[h]isoquinolines: novel and highly potent D1 dopamine agonistsFunctional selectivity of dopamine D1 receptor agonists in regulating the fate of internalized receptorsGenetic deletion of p90 ribosomal S6 kinase 2 alters patterns of 5-hydroxytryptamine 2A serotonin receptor functional selectivity.Pharmacology of signaling induced by dopamine D(1)-like receptor activationTreatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs.Identification of a 2-phenyl-substituted octahydrobenzo[f]quinoline as a dopamine D₃ receptor-selective full agonist ligand.Ligand-specific roles for transmembrane 5 serine residues in the binding and efficacy of dopamine D(1) receptor catechol agonistsReceptor conformations involved in dopamine D(2L) receptor functional selectivity induced by selected transmembrane-5 serine mutations.Structure-functional selectivity relationship studies of β-arrestin-biased dopamine D₂ receptor agonists.Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia.Analogues of doxanthrine reveal differences between the dopamine D1 receptor binding properties of chromanoisoquinolines and hexahydrobenzo[a]phenanthridinesHomology modeling of falcipain-2: validation, de novo ligand design and synthesis of novel inhibitors.Rh(iii)-Catalyzed intramolecular redox-neutral cyclization of alkenes via C–H activationRuthenium-Catalyzed Oxidative Coupling of Primary Amines with Internal Alkynes through CH Bond Activation: Scope and Mechanistic Studies
P2860
Q24605720-62A813E0-FCB5-408C-AF02-6B25A135171CQ24681428-FDED8E16-9672-4AE5-BFEB-C53397149B9FQ33714695-676278C2-C923-4039-AF4B-845817BE2C78Q34126949-0D5E34BF-B26E-42C7-9C87-60B2C06DD4F8Q34338202-A9AAAA85-631F-4B3B-9FD3-467EAB0F5AECQ34423308-7C63D04F-509A-4CDE-A0B0-F418BAED6B5BQ35913125-E3725E91-60F9-4FC4-8379-FAE625C2ED9DQ35996747-C9BD4DB5-21FD-4F1A-834A-9A4C834C8C2DQ36237653-CFE34F54-F43E-4CEA-8BDC-DAB06506AC7FQ38762256-B163CB5D-1CA2-4CBF-9086-C3249E41C379Q40618990-98BB5389-27BA-4DD3-858C-AE11A645D7A6Q43939666-1D098518-C72B-4BA7-9FEC-66940558B9A3Q57657148-419CC50E-F2EA-47CB-9FFF-BD1B2A9D2CE0Q57825483-6B7B4FEE-E980-413E-86B8-D1371BE84C77
P2860
9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore.
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
9-Dihydroxy-2,3,7,11b-tetrahyd ...... -phenyldopamine pharmacophore.
@ast
9-Dihydroxy-2,3,7,11b-tetrahyd ...... -phenyldopamine pharmacophore.
@en
9-Dihydroxy-2,3,7,11b-tetrahyd ...... -phenyldopamine pharmacophore.
@nl
type
label
9-Dihydroxy-2,3,7,11b-tetrahyd ...... -phenyldopamine pharmacophore.
@ast
9-Dihydroxy-2,3,7,11b-tetrahyd ...... -phenyldopamine pharmacophore.
@en
9-Dihydroxy-2,3,7,11b-tetrahyd ...... -phenyldopamine pharmacophore.
@nl
prefLabel
9-Dihydroxy-2,3,7,11b-tetrahyd ...... -phenyldopamine pharmacophore.
@ast
9-Dihydroxy-2,3,7,11b-tetrahyd ...... -phenyldopamine pharmacophore.
@en
9-Dihydroxy-2,3,7,11b-tetrahyd ...... -phenyldopamine pharmacophore.
@nl
P2093
P356
P1476
9-Dihydroxy-2,3,7,11b-tetrahyd ...... -phenyldopamine pharmacophore.
@en
P2093
P304
P356
10.1021/JM950707+
P407
P577
1996-01-01T00:00:00Z